| Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes A Soro-Paavonen, AMD Watson, J Li, K Paavonen, A Koitka, AC Calkin, ... Diabetes 57 (9), 2461-2469, 2008 | 492 | 2008 |
| miR-200a prevents renal fibrogenesis through repression of TGF-β2 expression B Wang, P Koh, C Winbanks, MT Coughlan, A McClelland, A Watson, ... diabetes 60 (1), 280-287, 2011 | 403 | 2011 |
| The neurochemical characterisation of hypothalamic pathways projecting polysynaptically to brown adipose tissue in the rat BJ Oldfield, ME Giles, A Watson, C Anderson, LM Colvill, MJ McKinley Neuroscience 110 (3), 515-526, 2002 | 328 | 2002 |
| E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-β B Wang, M Herman-Edelstein, P Koh, W Burns, K Jandeleit-Dahm, ... Diabetes 59 (7), 1794-1802, 2010 | 317 | 2010 |
| Leptin-induced nuclear translocation of STAT3 immunoreactivity in hypothalamic nuclei involved in body weight regulation T Hübschle, E Thom, A Watson, J Roth, S Klaus, W Meyerhof Journal of Neuroscience 21 (7), 2413-2424, 2001 | 231 | 2001 |
| Mechanisms of sympathetic activation in heart failure AMD Watson, SG Hood, CN May Clinical and experimental pharmacology and physiology 33 (12), 1269-1274, 2006 | 153 | 2006 |
| Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions AMD Watson, GW Lambert, KJ Smith, CN May Hypertension 42 (3), 373-379, 2003 | 132 | 2003 |
| The AGE/RAGE axis in diabetes‐accelerated atherosclerosis K Jandeleit‐Dahm, A Watson, A Soro‐Paavonen Clinical and Experimental Pharmacology and Physiology 35 (3), 329-334, 2008 | 131 | 2008 |
| The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice AMD Watson, J Li, C Schumacher, M De Gasparo, B Feng, MC Thomas, ... Diabetologia 53, 192-203, 2010 | 100 | 2010 |
| A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH/2J genetically hypertensive mice KL Jackson, FZ Marques, AMD Watson, K Palma-Rigo, TP Nguyen-Huu, ... Hypertension 62 (4), 775-781, 2013 | 88 | 2013 |
| Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice AMD Watson, A Soro-Paavonen, K Sheehy, J Li, AC Calkin, A Koitka, ... Diabetologia 54, 681-689, 2011 | 87 | 2011 |
| Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex AMD Watson, SG Hood, R Ramchandra, RM McAllen, CN May American Journal of Physiology-Heart and Circulatory Physiology 293 (1 …, 2007 | 87 | 2007 |
| Linking RAGE and Nox in diabetic micro-and macrovascular complications C Koulis, AMD Watson, SP Gray, KA Jandeleit-Dahm Diabetes & metabolism 41 (4), 272-281, 2015 | 81 | 2015 |
| Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice AMD Watson, SP Gray, L Jiaze, A Soro-Paavonen, B Wong, ME Cooper, ... Diabetes 61 (8), 2105-2113, 2012 | 71 | 2012 |
| The emerging role of NADPH oxidase NOX5 in vascular disease JC Jha, AMD Watson, G Mathew, LC de Vos, K Jandeleit-Dahm Clinical Science 131 (10), 981-990, 2017 | 64 | 2017 |
| Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep AMD Watson, R Mogulkoc, RM McAllen, CN May American Journal of Physiology-Regulatory, Integrative and Comparative …, 2004 | 61 | 2004 |
| Urotensin II, a novel peptide in central and peripheral cardiovascular control AMD Watson, CN May Peptides 25 (10), 1759-1766, 2004 | 52 | 2004 |
| Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure R Ramchandra, SG Hood, AMD Watson, AM Allen, CN May Hypertension 59 (3), 634-641, 2012 | 51 | 2012 |
| Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes AMD Watson, M Olukman, C Koulis, Y Tu, D Samijono, D Yuen, C Lee, ... Diabetologia 56, 1155-1165, 2013 | 50 | 2013 |
| The superoxide dismutase mimetic tempol blunts diabetes-induced upregulation of NADPH oxidase and endoplasmic reticulum stress in a rat model of diabetic nephropathy MJ De Blasio, A Ramalingam, AH Cao, D Prakoso, JM Ye, R Pickering, ... European journal of pharmacology 807, 12-20, 2017 | 44 | 2017 |
